TrialAmerican journal of respiratory and critical care medicine2025

Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial.

Patrick P J Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.